Vicki Sato
InvestorVenture Partner at ARCH Venture Partners
Cambridge, Massachusetts
Writes $50K – $150M checks · typically $25M
FoundedDenali Therapeutics
Deals · 1
Syros Pharmaceuticals, Inc.Board seat
via ARCH Venture Partners · filed Feb 2018 · $11.4M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at ARCH Venture Partners
Ari Nowacek
Partner at ARCH Venture Partners
Axel Bouchon
Venture Partner at ARCH Venture Partners
Brian Cuneo
Senior Partner at ARCH Venture Partners
Carol Suh
Partner at ARCH Venture Partners
Clinton Bybee
Co-founder & Managing Director, Emeritus at ARCH Venture Partners
Corey Ritter
Partner at ARCH Venture Partners
David Moore
Senior Partner at ARCH Venture Partners
George Scangos
Venture Partner at ARCH Venture Partners






